{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:49:13Z","timestamp":1791910153927,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.amjmed.2009.09.038","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T04:44:40Z","timestamp":1271393080000},"page":"400-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Management of Hepatitis C Virus-related Mixed Cryoglobulinemia"],"prefix":"10.1016","volume":"123","author":[{"given":"Francesco","family":"Iannuzzella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Garini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2009.09.038_bib1","first-page":"156","article-title":"Hypoproteinemia associated with multiple myeloma","volume":"52","author":"Wintrobe","year":"1933","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.amjmed.2009.09.038_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(62)90191-2","article-title":"Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin","volume":"32","author":"Lospalluto","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","article-title":"Cryoglobulinemic vasculitis","volume":"42","author":"Lamprecht","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2009.09.038_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/infdis\/162.2.569","article-title":"Hepatitis C virus in patients with cryoglobulinemia type II","volume":"162","author":"Pascual","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0140-6736(91)92715-E","article-title":"Cryoglobulinemia and hepatitis C virus","volume":"337","author":"Casato","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2009.09.038_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0140-6736(91)92014-S","article-title":"Cryoglobulinemia and hepatitis C virus infection","volume":"338","author":"Disdier","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2009.09.038_bib9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib10","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease","volume":"88","author":"Monti","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.amjmed.2009.09.038_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/rheumatology\/32.8.689","article-title":"Hepatitis C virus and essential mixed cryoglobulinemia","volume":"32","author":"Cacoub","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjmed.2009.09.038_bib13","first-page":"79","article-title":"Mixed cryoglobulinemia crossreactive idiotypes: Implications for the relationship of MC to rheumatic and lymphoproliferative diseases","volume":"28","author":"Gorevic","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00945029","article-title":"The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection","volume":"19","author":"Agnello","year":"1997","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.amjmed.2009.09.038_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/jhep.2002.35620","article-title":"Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis","volume":"36","author":"Kayali","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jhep.2003.10.009","article-title":"Extrahepatic disease manifestations of HCV infection: some current issues","volume":"40","author":"Agnello","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","article-title":"Hepatitis C virus-associated extrahepatic manifestations: a review","volume":"19","author":"S\u00e8ne","year":"2004","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevich","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0002-9343(66)90199-9","article-title":"Cryoglobulinemia: a study of 29 patients. I","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2009.09.038_bib23","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.1780401113","article-title":"Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia","volume":"40","author":"Agnello","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2009.09.038_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ki.1994.393","article-title":"Renal manifestations of hepatitis C virus infection","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2009.09.038_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2009.09.038_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","article-title":"Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis","volume":"54","author":"D'Amico","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2009.09.038_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.mnh.0000172729.60122.f9","article-title":"Pathogenic mechanism in membranoproliferative glomerulonephritis","volume":"14","author":"Smith","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.amjmed.2009.09.038_bib29","first-page":"391","article-title":"High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinemia","volume":"30","author":"Zaltron","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.60.6.661","article-title":"Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?","volume":"60","author":"Apartis","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjmed.2009.09.038_bib31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1468-1331.2006.01416.x","article-title":"Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection","volume":"13","author":"Boukhris","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2008.07.027","article-title":"Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia","volume":"8","author":"Alpa","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.amjmed.2009.09.038_bib33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.57.12.728","article-title":"Cryoglobulinemia and rheumatic manifestations in patients with hepatitis C virus infection","volume":"57","author":"Lee","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2005.038042","article-title":"Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sj\u00f6gren's syndrome","volume":"65","author":"Sene","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1253\/jcj.62.389","article-title":"Hepatitis C virus infection and heart diseases: a multicenter study in Japan","volume":"62","author":"Matsumori","year":"1998","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.amjmed.2009.09.038_bib36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/35.10.978","article-title":"Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus","volume":"35","author":"Manganelli","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/rheumatology\/36.3.360","article-title":"Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection","volume":"36","author":"Ferri","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5858\/1999-123-0119-EOC","article-title":"Evaluation of cryoglobulins","volume":"123","author":"Kallemuchikkal","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib39","first-page":"1","article-title":"NIH Consensus Statement on Management of Hepatitis C: 2002","volume":"19","year":"2002","journal-title":"NIH Consens State Sci Statements"},{"key":"10.1016\/j.amjmed.2009.09.038_bib40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2009.09.038_bib41","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha 2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2005.11.010","article-title":"American Gastroenterological Association technical review on the management on hepatitis C","volume":"130","author":"Dienstag","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib44","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","article-title":"Side effects of therapy for chronic hepatitis C","volume":"124","author":"Russo","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib45","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","article-title":"Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia","volume":"78","author":"Casato","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.09.038_bib46","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-\u03b1 in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.09.038_bib47","first-page":"342","article-title":"Long-term effects of alpha interferon therapy for type II mixed cryoglobulinemia","volume":"79","author":"Mazzaro","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.amjmed.2009.09.038_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib49","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.amjmed.2009.09.038_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(97)80281-4","article-title":"Interferon-\u03b1 treatment hepatitis C virus-associated mixed cryoglobulinemia","volume":"27","author":"Polzien","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib51","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V92.8.2983","article-title":"Interferon-\u03b1 and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia","volume":"92","author":"Donada","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.09.038_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gut.45.1.122","article-title":"Response to interferon \u03b1 treatment and disappearance of cryoglobulinemia in patients infected by hepatitis C virus","volume":"45","author":"Cresta","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2009.09.038_bib53","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha","volume":"27","author":"Zuckerman","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib54","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1053\/ajkd.2001.29291","article-title":"Interferon-alfa in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis","volume":"38","author":"Garini","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib55","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/ndt\/17.11.1924","article-title":"Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy","volume":"17","author":"Sabry","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2009.09.038_bib56","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1046\/j.1523-1755.2003.00022.x","article-title":"Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy","volume":"63","author":"Rossi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2009.09.038_bib57","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib58","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2009.09.038_bib59","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"6","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.amjmed.2009.09.038_bib60","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70140-X","article-title":"Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy","volume":"33","author":"Otha","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib61","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ndt\/gfg209","article-title":"Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency","volume":"18","author":"Bruchfeld","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2009.09.038_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cgh.2008.10.035","article-title":"Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C","volume":"7","author":"Nelson","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2007.02.018","article-title":"Virological response and safety outcomes in therapy-na\u00efve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study","volume":"47","author":"Gish","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib64","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature04080","article-title":"Challenges and successes in developing new therapies for hepatitis C","volume":"436","author":"De Francesco","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2009.09.038_bib65","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa0807650","article-title":"Telaprevir and peginterferon with or without ribavirin for chronic HCV infection","volume":"360","author":"H\u00e9zode","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib66","first-page":"249A","article-title":"Relationships of HCV RNA responses to CPG, a TLR agonist, pharmacodynamics and patient characteristics","volume":"42","author":"McHutchison","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib67","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21773","article-title":"Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus","volume":"46","author":"McHutchison","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib68","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","article-title":"Cryoglobulinemic vasculitis","volume":"42","author":"Lamprecht","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2009.09.038_bib69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ndt\/14.2.281","article-title":"Glomerulonephritis in mixed cryoglobulinemia: what treatment?","volume":"14","author":"Campise","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2009.09.038_bib70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.10107","article-title":"Hepatitis C virus infection and vasculitis","volume":"46","author":"Vassilopoulos","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2009.09.038_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000089667","article-title":"Mycophenolate mofetil in anti-neutrophil cytoplasm antobodies-associated systemic vasculitis","volume":"102","author":"Koukoulaki","year":"2006","journal-title":"Nephron Clin Pract"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2009.09.038_bib72","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/096120330501400114","article-title":"Mycophenolate mofetil in patients with hepatitis C virus infection","volume":"14","author":"Ramos-Casals","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.amjmed.2009.09.038_bib73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ndt\/16.4.869-a","article-title":"Hepatitis C-associated glomerulonephritis\u2014a novel therapeutic approach","volume":"16","author":"Reed","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2009.09.038_bib74","first-page":"S47","article-title":"Prolonged plasma exchange in the treatment of renal involvement in essential mixed cryoglobulinemia","volume":"6","author":"Bombardieri","year":"1983","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.amjmed.2009.09.038_bib75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jca.20166","article-title":"Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia","volume":"23","author":"Ramunni","year":"2008","journal-title":"J Clin Apher"},{"key":"10.1016\/j.amjmed.2009.09.038_bib76","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.09.038_bib77","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.09.038_bib78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOR.0b013e3282f1330c","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"Saadoun","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib79","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2002.004929","article-title":"Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis","volume":"62","author":"Lamprecht","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib80","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.coph.2004.03.006","article-title":"Anti B cell therapy (rituximab) in the treatment of autoimmune diseases","volume":"4","author":"Kazkaz","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib81","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2009.09.038_bib82","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1053\/j.ajkd.2003.12.057","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C\u2013negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure","volume":"43","author":"Ghijsels","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2009.09.038_bib83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","article-title":"Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab","volume":"20","author":"Koukoulaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2009.09.038_bib84","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib85","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-\u03b1 antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib86","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keh080","article-title":"Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinemia","volume":"43","author":"Chandesris","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjmed.2009.09.038_bib87","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1196\/annals.1423.058","article-title":"Safety of cyclosporin A in HCV-infected patients","volume":"1110","author":"Galeazzi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.amjmed.2009.09.038_bib88","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(89)80607-2","article-title":"Low-antigen-content diet in the treatment of mixed cryoglobulinemia patients","volume":"87","author":"Ferri","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.09.038_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidlines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib90","first-page":"912","article-title":"Successful treatment of necrotizing vasculitic lesions after infusion of iloprost in a patient with cryoglobulinemia and chronic HCV infection","volume":"23","author":"Lo Gullo","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 13","key":"10.1016\/j.amjmed.2009.09.038_bib91","first-page":"S197","article-title":"Colchicine in the treatment of mixed cryoglobulinemia","volume":"13","author":"Monti","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjmed.2009.09.038_bib92","first-page":"671","article-title":"Disease assessment and management of the vasculitides","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.amjmed.2009.09.038_bib93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/art.1780370622","article-title":"Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis","volume":"37","author":"Reinhold-Keller","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"Suppl 109","key":"10.1016\/j.amjmed.2009.09.038_bib94","first-page":"S20","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease","volume":"73","year":"2008","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2009.09.038_bib95","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:53:08Z","timestamp":1757580788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934310000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0002934310000161"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.09.038","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Hepatitis C Virus-related Mixed Cryoglobulinemia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}